Marcel M C Hovens

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Coronavirus Disease

Direct Oral Anticoagulants

Top Venues

BMC pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Monique M R de Maat, Henk J van Leeuwen, Elisabeth A Roovers, Sabine J G M Ahlers, Jolanda Lambers, Marcel M C Hovens
Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patients. BMC pharmacology & toxicology 25 (1) (2024)
Monique M R de Maat, Henk J van Leeuwen, Elisabeth A Roovers, Sabine J G M Ahlers, Jolanda Lambers, Marcel M C Hovens
Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patients. BMC pharmacology & toxicology 25 (1) (2024)
Monique M R de Maat, Henk J van Leeuwen, Elisabeth A Roovers, Sabine J G M Ahlers, Jolanda Lambers, Marcel M C Hovens
Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patients. BMC pharmacology & toxicology 25 (1) (2024)